| Dr James A Reiss, MD | |
|
200 Ne Mother Joseph Pl, Suite 400, Vancouver, WA 98664-3299 | |
| (360) 256-2640 | |
| (360) 260-7288 |
| Full Name | Dr James A Reiss |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 29 Years |
| Location | 200 Ne Mother Joseph Pl, Vancouver, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285683482 | NPI | - | NPPES |
| 8277337 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD00035204 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peacehealth Southwest Medical Center | Vancouver, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peacehealth | 9739092065 | 86 |
News Archive
Scientists at the University of Kent have made a significant discovery about how the vitamin content of some plants can be improved to make vegetarian and vegan diets more complete.
The U.S. Department of Health and Human Services (HHS) today marked the recent approval of the 100th antiretroviral drug in association with the President's Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS worldwide.
More than 100 million people in this country have pain that won't go away. Many of these chronic pain sufferers fail to get relief from pills, shots and even surgery, while others temporarily trade the pain for side effects such as drowsiness or digestive problems.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
As HIV spreads beyond high-risk groups into China's general population, drug-resistant strains of the virus also are appearing in parts of the country, Chen Zhiwei of the AIDS Institute in Hong Kong said recently, Reuters reports.
› Verified 4 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134178999 PECOS PAC ID: 9739092065 Enrollment ID: O20031111000831 |
News Archive
Scientists at the University of Kent have made a significant discovery about how the vitamin content of some plants can be improved to make vegetarian and vegan diets more complete.
The U.S. Department of Health and Human Services (HHS) today marked the recent approval of the 100th antiretroviral drug in association with the President's Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS worldwide.
More than 100 million people in this country have pain that won't go away. Many of these chronic pain sufferers fail to get relief from pills, shots and even surgery, while others temporarily trade the pain for side effects such as drowsiness or digestive problems.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
As HIV spreads beyond high-risk groups into China's general population, drug-resistant strains of the virus also are appearing in parts of the country, Chen Zhiwei of the AIDS Institute in Hong Kong said recently, Reuters reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James A Reiss, MD 200 Ne Mother Joseph Pl, Suite 400, Vancouver, WA 98664-3299 Ph: (360) 256-2640 | Dr James A Reiss, MD 200 Ne Mother Joseph Pl, Suite 400, Vancouver, WA 98664-3299 Ph: (360) 256-2640 |
News Archive
Scientists at the University of Kent have made a significant discovery about how the vitamin content of some plants can be improved to make vegetarian and vegan diets more complete.
The U.S. Department of Health and Human Services (HHS) today marked the recent approval of the 100th antiretroviral drug in association with the President's Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS worldwide.
More than 100 million people in this country have pain that won't go away. Many of these chronic pain sufferers fail to get relief from pills, shots and even surgery, while others temporarily trade the pain for side effects such as drowsiness or digestive problems.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
As HIV spreads beyond high-risk groups into China's general population, drug-resistant strains of the virus also are appearing in parts of the country, Chen Zhiwei of the AIDS Institute in Hong Kong said recently, Reuters reports.
› Verified 4 days ago
Kanuboddu Nagarjuna Reddy, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave Ste 220, Vancouver, WA 98664 Phone: 360-882-2778 | |
Dr. David Steiger, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 505 Ne 87th Ave Ste 301, Vancouver, WA 98664 Phone: 360-514-7374 Fax: 360-514-7384 | |
Phillip M Cullison Bonner, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2211 Ne 139th St, Vancouver, WA 98686 Phone: 360-487-1000 | |
Louise M Schultz, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-882-2778 | |
Marissa Krienke, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 700 Ne 87th Ave Ste And240, Vancouver, WA 98664 Phone: 360-882-2778 | |
Joel David Mclarry, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Suite 210, Vancouver, WA 98664 Phone: 360-882-2778 | |
Dr. Samuel Everett George, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 19005 Se 34th St Bldg 3, Vancouver, WA 98683 Phone: 360-726-6720 Fax: 360-726-6729 |